Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux

被引:179
作者
Dabholkar, Rupa D.
Sawant, Rishikesh M.
Mongayt, Dimitriy A.
Devarajan, Padma V.
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA
[2] Univ Inst Chem Technol, Dept Pharmaceut Sci, Bombay, Maharashtra, India
关键词
paclitaxel; mixed micelles; PEG-PE; TPGS; Caco-2; cells; P-glycoprotein;
D O I
10.1016/j.ijpharm.2006.02.018
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Mixed micelles prepared of poly(ethylene glycol)2000-phosphatidyl ethanolamine conjugate (PEG(2000)-PE) and D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) in 1:1 molar ratio have been investigated. Micelle formation was confirmed by NMR spectroscopy. CMC of the micelles was found to be 1.5 x 10(-5) M. Poorly soluble anti-cancer drug paclitaxel (PCL) was efficiently solubilized in 15 nm non-toxic PEG-PE/TPGS micelles. PCL entrapment was quite stable with only about 20% of the incorporated drug released from micelles after 48 h at 37 degrees C. In addition, PCL-containing PEG(2000)-PE/TPGS micelles were stable in vitro under various conditions modeling the physiological ones, in particular, at low pH values and in the presence of bile acids, which is especially important for their possible oral administration. Fluorescently labeled micelles demonstrated time-dependent internalization by human colon adenocarcinoma cell line, Caco-2. The internalization of PEG(2000)-PE/TPGS micelles loaded with P-glycoprotein (P-gp) substrate, rhodamine-123 (RH-123), opposite to the internalization of the free RH-123, was not influenced by the inhibition of the P-gp pump with verapamil hydrochloride, which assumes a P-gp-independent micelle internalization. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:148 / 157
页数:10
相关论文
共 32 条
[1]
ADLER LM, 1994, CANCER, V74, P1891, DOI 10.1002/1097-0142(19941001)74:7<1891::AID-CNCR2820740711>3.0.CO
[2]
2-K
[3]
A MIXED MICELLAR FORMULATION SUITABLE FOR THE PARENTERAL ADMINISTRATION OF TAXOL [J].
ALKANONYUKSEL, H ;
RAMAKRISHNAN, S ;
CHAI, HB ;
PEZZUTO, JM .
PHARMACEUTICAL RESEARCH, 1994, 11 (02) :206-212
[4]
Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) [J].
Dintaman, JM ;
Silverman, JA .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1550-1556
[5]
CLINICAL-STUDIES WITH MODULATORS OF MULTIDRUG-RESISTANCE [J].
FISHER, GA ;
SIKIC, BI .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (02) :363-382
[6]
PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing [J].
Gao, Z ;
Lukyanov, AN ;
Chakilam, AR ;
Torchilin, VP .
JOURNAL OF DRUG TARGETING, 2003, 11 (02) :87-92
[7]
Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs [J].
Gao, ZG ;
Lukyanov, AN ;
Singhal, A ;
Torchilin, VP .
NANO LETTERS, 2002, 2 (09) :979-982
[8]
Guastalla J P, 1994, Ann Oncol, V5 Suppl 6, pS33
[9]
HOFSLI E, 1990, CANCER RES, V50, P3997
[10]
Kubota T, 1997, J SURG ONCOL, V64, P115, DOI 10.1002/(SICI)1096-9098(199702)64:2<115::AID-JSO5>3.3.CO